首页|FeNO50+CaNO联合检测对慢性阻塞性肺疾病急性加重期激素治疗的应用价值

FeNO50+CaNO联合检测对慢性阻塞性肺疾病急性加重期激素治疗的应用价值

The Application Value of Feno50+CaNo Combined Detection in Hormone Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease

扫码查看
目的:探讨呼出气流速为 50 mL·s-1 时呼出气一氧化氮(FeNO50)+肺泡呼出气一氧化氮(CaNO)联合检测对慢性阻塞性肺疾病急性加重期(AECOPD)患者使用糖皮质激素治疗的应用价值.方法:前瞻性地纳入2021年6月1日至2023年5月31日在深圳市第二人民医院呼吸与危重症医学科住院的AECOPD患者62例.根据入院时FeNO50、CaNO水平分为4组(Ⅰ组:FeNO50<25 ppb,CaNO≤5 ppb;Ⅱ组:FeNO50≥25 ppb,CaNO≤5 ppb;Ⅲ组:FeNO50<25 ppb,CaNO>5 ppb;Ⅳ组:FeNO50≥25 ppb,CaNO>5 ppb).对所有患者使用全身糖皮质激素治疗.分别记录入院时及出院时的FeNO50 水平、CaNO水平、外周血嗜酸性粒细胞(EOS)、肺功能[第 1 秒用力呼气容积(FEV1)]、慢性阻塞性肺疾病评估测试(CAT)评分.使用Pearson相关性分析EOS、FeNO50、CaNO三者关系,比较 4 组间FEV1、CAT评分治疗前后的改善值变化情况;采用受试者工作特征曲线(ROC)分析FeNO50、CaNO、EOS对治疗后肺功能改善的预测价值.结果:各组患者的年龄、性别、身体质量指数(BMI)、吸烟史及平素症状之间比较,差异无统计学意义(P>0.05).Pearson分析提示入院时EOS与FeNO50 呈正相关(r=0.521,P<0.05);经过治疗,EOS改善值与FeNO50 改善值呈正相关(r=0.472,P<0.05).经全身糖皮质激素治疗后,4 组间FEV1 改善值、CAT评分改善值差异均有统计学意义(P<0.001;P=0.002);Ⅳ组患者较其他三组FEV1 改善值更明显,差异有统计学意义(P<0.05),Ⅲ组和Ⅳ组患者较其他两组CAT评分改善更明显,差异有统计学意义(P<0.05).ROC曲线下面积未观察到EOS、FeNO50、CaNO对AECOPD患者治疗后肺功能显著改善有明显预测价值.结论:FeNO50+CaNO联合检测对AECOPD患者使用全身糖皮质激素疗效具有一定的预测作用,FeNO50 与CaNO均升高的患者经全身糖皮质激素治疗后肺功能的改善更明显,而CANO升高的患者治疗后症状的改善更明显,但有待扩大样本量进一步验证.
Objective To explore the application value of combined detection of fractional exhaled nitric oxide at an exhaled airflow rate of 50 mL·s-1(FeNO50)and alveolar exhaled nitric oxide(CaNO)in the treatment of acute exacerbation of chronic obstructive pulmonary disease(AECOPD)with glucocorticoids.Methods Prospective enrollment of 62 AECOPD patients admitted to the Department of Respiratory and Critical Care Medicine at Shenzhen Second People's Hospital from June 1,2021 to May 31,2023.They were categorized into four groups based on their FeNO50 and CaNO levels upon admission(Group Ⅰ:FeNO50<25 ppb,CaNO≤5 ppb;Group Ⅱ:FeNO50≥25 ppb,CaNO≤5 ppb;Group Ⅲ:FeNO50<25 ppb,CaNO>5 ppb;Group Ⅳ:FeNO50≥25 ppb,CaNO>5 ppb).All patients received treatment with systemic glucocorticoids.The levels of FeNO50,CaNO,peripheral blood eosinophils(EOS),pulmonary function[(forced expiratory volume in the first second(FEV1)],and chronic obstructive pulmonary disease assessment test(CAT)scores were measured at admission and discharge.Pearson correlation analysis was conducted to examine the relationship between EOS,FeNO50,and CaNO.The improvement in FEV1 and CAT scores before and after treatment was compared among the 4 groups.Furthermore,the predictive value of FeNO50,CaNO,and EOS on lung function improvement after treatment was assessed using receiver operating characteristic curve(ROC).Results There were no significant differences in age,sex,body mass index(BMI),smoking history and normal symptoms among all groups(P>0.05).Pearson analysis showed that there was a positive correlation between EOS and FeNO50(r=0.521,P<0.05).After treatment,the improvement value of EOS was positively correlated with that of FeNO50(r=0.472,P<0.05).After systemic glucocorticoid treatment,there were statistically significant differences in FEV1 improvement and CAT score improvement among the 4 groups(P<0.001;P=0.002).Compared with the other three groups,the improvement of FEV1 in group Ⅳ was more obvious,and the difference was statistically significant(P<0.05);the improvement of CAT scores in group Ⅲ and Ⅳ were more obvious than those in the other two groups,and the differences were statistically significant(P<0.05).No significant predictive value of EOS,FeNO50 and CaNO was observed in the area under ROC curve for the significant improvement of lung function in patients with AECOPD after treatment.Conclusion The combined detection of FeNO50+CaNO has a certain predictive effect on the efficacy of systemic glucocorticoid in AECOPD patients.Patients with both elevated FeNO50 and CaNO have more obvious improvement in lung function after systemic glucocorticoid treatment,while patients with elevated CANO have more obvious improvement in symptoms after treatment.However,the sample size needs to be expanded for further verification.

Acute exacerbation of chronic obstructive pulmonary diseaseExhaled breath nitric oxideAlveolar nitric oxideCombined testPeripheral blood eosinophil count

刘茜、张敏、武莉莉

展开 >

深圳市第二人民医院,广东 深圳 518035

深圳大学,广东 深圳 518000

慢性阻塞性肺疾病急性加重期 呼出气一氧化氮 肺泡呼出气一氧化氮 联合检测 外周血嗜酸性粒细胞计数

深圳市第二人民医院院级临床研究项目

20213357029

2024

深圳中西医结合杂志
深圳市中西医结合临床研究所

深圳中西医结合杂志

影响因子:0.692
ISSN:1007-0893
年,卷(期):2024.34(7)